Seth Klarman's CME Position Overview
Seth Klarman (via Baupost Group Llc/Ma) currently holds 619,000 shares of CME Group Inc. (CME) worth $136.69 M, representing 2.52% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Seth Klarman has initiated a new position in CME, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Seth Klarman's CME Group (CME) Holding Value Over Time
Track share changes against reported price movement
Quarterly CME Group (CME) Trades by Seth Klarman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +619,000 | New Buy | 619,000 | $220.83 |
Seth Klarman's CME Group Investment FAQs
Seth Klarman first purchased CME Group Inc. (CME) in Q2 2026, acquiring 619,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Seth Klarman has held CME Group Inc. (CME) for 1 quarters since Q2 2026.
Seth Klarman's largest addition to CME Group Inc. (CME) was in Q2 2026, adding 619,000 shares worth $136.69 M.
According to the latest 13F filing for Q2 2026, Seth Klarman's firm, Baupost Group Llc/Ma, owns 619,000 shares of CME Group Inc. (CME), valued at approximately $136.69 M.
As of the Q2 2026 filing, CME Group Inc. (CME) represents approximately 2.52% of Seth Klarman's publicly disclosed stock portfolio, making it one of their key holdings.
Seth Klarman's peak holding in CME Group Inc. (CME) was 619,000 shares, as reported at the end of Q2 2026.